Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Type;
Diagnostic Devices, Therapeutic Devices, and Monitoring Devices.By End User;
Hospitals, Clinics, Homecare Settings, and Ambulatory Service Centers.By Therapeutic Devices;
Humidifiers, Nebulizers, Oxygen Concentrators, Positive Airway Pressure (PAP) Devices, Ventilators, and Others.By Diagnostic Devices;
Spirometer, Polysomnographs, and Peak Flow Meters.By Monitoring Devices;
Pulse Oximeters, Capnographs, and Gas Analyzers.By Application;
Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis, and Pneumonia.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market (USD Million), 2021 - 2031
In the year 2024, the Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market was valued at USD 35,371.32 million. The size of this market is expected to increase to USD 78,665.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 12.1%.
The global respiratory devices and equipment market, encompassing both therapeutic and diagnostic tools, is experiencing a significant surge in demand. This growth is propelled by several factors, including the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, alongside increasing awareness and diagnosis rates worldwide. Additionally, the COVID-19 pandemic has spotlighted the critical need for respiratory support devices, driving further expansion in this market segment.
Therapeutic respiratory devices, including ventilators, continuous positive airway pressure (CPAP) machines, and nebulizers, are vital in managing respiratory conditions and providing life-saving support for patients with acute or chronic respiratory failure. These devices are seeing heightened adoption not only in hospitals and clinical settings but also in homecare environments, where patients seek convenient and effective ways to manage their conditions. Furthermore, advancements in technology, such as miniaturization and improved portability, are enhancing the accessibility and usability of these devices, further fueling market growth.
On the diagnostic front, respiratory equipment plays a crucial role in assessing lung function, identifying respiratory disorders, and monitoring disease progression. Innovations in diagnostic tools, such as spirometers, peak flow meters, and pulse oximeters, are enabling more accurate and efficient respiratory assessments. With a growing emphasis on preventive healthcare and early disease detection, the demand for diagnostic respiratory equipment is expected to continue rising, driving market expansion and fostering innovation in the years ahead.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Recent Developments
-
In 2023, ResMed expanded its line of CPAP devices to support a growing demand in therapeutic respiratory care, focusing on enhanced usability and patient monitoring
-
In 2022, rapid advancements in diagnostic imaging for respiratory care improved early detection and treatment of chronic respiratory diseases, driving market growth
Segment Analysis
The global respiratory devices and equipment market is projected to witness significant growth from 2024 to 2030, driven by several factors such as the increasing prevalence of respiratory diseases, technological advancements in respiratory devices, and growing awareness about respiratory health. The market is segmented into diagnostic devices, therapeutic devices, and monitoring devices, catering to various end-users including hospitals, clinics, homecare settings, and ambulatory service centers.
Therapeutic devices, a crucial segment within the market, include humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, and others. These devices play a pivotal role in managing respiratory conditions such as asthma, obstructive sleep apnea (OSA), respiratory distress syndrome (RDS), cystic fibrosis, and pneumonia. Similarly, diagnostic devices such as spirometers, polysomnographs, and peak flow meters enable healthcare professionals to accurately diagnose respiratory disorders and monitor disease progression.
Monitoring devices like pulse oximeters, capnographs, and gas analyzers are essential for continuous monitoring of patients with respiratory conditions, both in clinical settings and at home. Geographically, North America, Europe, Asia Pacific, Middle East and Africa, and Latin America are key regions contributing to the growth of the respiratory devices and equipment market. With increasing healthcare expenditure, rising geriatric population, and the prevalence of respiratory diseases, these regions are expected to witness substantial market growth during the forecast period.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Segment Analysis
In this report, the Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by Type, End User, Therapeutic Devices, Diagnostic Devices, Monitoring Devices, Application and Geography.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, Segmentation by Type
The Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by Type into Diagnostic devices, Therapeutic devices and Monitoring devices.
The Global Respiratory Devices and Equipment market has witnessed significant segmentation by type, encompassing diagnostic devices, therapeutic devices, and monitoring devices. Each segment plays a crucial role in managing respiratory conditions and diseases, contributing to the overall growth of the market. Diagnostic devices are fundamental in identifying respiratory disorders, allowing healthcare professionals to make accurate diagnoses and devise appropriate treatment plans. These devices range from spirometers to peak flow meters, aiding in assessing lung function and identifying abnormalities such as asthma or chronic obstructive pulmonary disease (COPD).
Therapeutic devices form another vital segment within the respiratory devices market, encompassing a wide array of equipment aimed at managing respiratory conditions and improving patients' quality of life. Inhalers, nebulizers, and positive airway pressure devices are among the key therapeutic devices utilized to deliver medications or assist in breathing for individuals with respiratory ailments. Additionally, advancements in technology have led to the development of innovative therapeutic devices, offering more efficient and targeted treatment options for patients.
Monitoring devices constitute an integral part of respiratory care, facilitating continuous assessment and management of patients' respiratory status. These devices include pulse oximeters, capnographs, and respiratory rate monitors, providing real-time data on vital respiratory parameters. Such monitoring enables healthcare professionals to closely monitor patients in various settings, including hospitals, clinics, and home care settings, thereby optimizing treatment strategies and enhancing patient outcomes. The segmentation of the Global Respiratory Devices and Equipment market underscores the diverse range of tools available for diagnosing, treating, and monitoring respiratory conditions, reflecting ongoing advancements in respiratory care.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, Segmentation by End User
The Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by End User into Hospitals, Clinics, Homecare settings and Ambulatory service centers.
The Global Respiratory Devices and Equipment market, encompassing both therapeutic and diagnostic tools, has witnessed significant segmentation based on end-users. Hospitals, with their advanced infrastructure and round-the-clock medical care, constitute a pivotal segment. They often serve as the primary hub for respiratory care, equipped with various devices to diagnose and treat respiratory ailments effectively. Additionally, clinics play a crucial role, especially for outpatient care and initial diagnosis. Their accessibility and specialized focus on respiratory health make them essential in managing respiratory conditions efficiently.
The growing trend of homecare settings as a preferred option for managing chronic respiratory diseases has fueled the demand for respiratory devices in this segment. Homecare settings offer patients the convenience of receiving care in the comfort of their own homes while reducing healthcare costs associated with hospital stays. With advancements in technology, many respiratory devices are now designed to be user-friendly and portable, facilitating their use in home environments. Lastly, ambulatory service centers serve as convenient points of access for respiratory care, offering services outside traditional hospital settings. These centers cater to patients requiring immediate respiratory assistance or ongoing monitoring, contributing significantly to the overall respiratory devices and equipment market.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, Segmentation by Therapeutic Devices
The Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by Therapeutic Devices into Humidifiers, Nebulizers, Oxygen concentrators, Positive Airway Pressure (PAP) Devices, Ventilators and Others.
The Global Respiratory Devices and Equipment market has seen significant segmentation, particularly in therapeutic devices, to cater to diverse respiratory needs. These devices play a crucial role in managing various respiratory conditions and improving patients' quality of life. Among the segmented therapeutic devices are humidifiers, nebulizers, oxygen concentrators, positive airway pressure (PAP) devices, ventilators, and others. Each category addresses specific respiratory challenges, from humidifying air to delivering medications efficiently or ensuring adequate oxygen supply. This segmentation allows for targeted solutions tailored to different patient requirements, reflecting the market's commitment to innovation and patient-centric care.
Humidifiers are vital in maintaining optimal humidity levels for individuals with respiratory conditions, preventing dryness and irritation in the airways. Nebulizers offer effective delivery of medications in mist form, benefiting patients with conditions like asthma or chronic obstructive pulmonary disease (COPD). Oxygen concentrators provide a continuous and reliable oxygen supply, essential for patients with respiratory insufficiency or those requiring long-term oxygen therapy. Positive airway pressure (PAP) devices, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP), assist in treating sleep apnea and other sleep-related breathing disorders by keeping airways open during sleep. Ventilators are critical life-support devices that assist patients with severe respiratory failure or those undergoing surgery, ensuring proper oxygenation and ventilation. This segmentation underscores the diverse range of respiratory devices available, reflecting the industry's commitment to advancing respiratory care and enhancing patient outcomes.
The segmented nature of the Global Respiratory Devices and Equipment market reflects the nuanced approach required in respiratory therapy, acknowledging the varied needs of patients with respiratory disorders. This segmentation allows healthcare providers to choose the most appropriate devices for individual patients, optimizing treatment outcomes and enhancing patient comfort and compliance. Additionally, it fosters innovation and competition among manufacturers, driving advancements in technology and device design to meet evolving clinical needs. As the prevalence of respiratory diseases continues to rise globally, fueled by factors such as air pollution and aging populations, the demand for specialized respiratory devices is expected to grow, further driving market segmentation and innovation in respiratory care.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, Segmentation by Diagnostic Devices
The Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by Diagnostic Devices into Spirometer, Polysomnographs and Peak Flow Meters.
The Global Respiratory Devices And Equipment market has witnessed significant segmentation in its diagnostic devices category, which plays a crucial role in assessing and monitoring respiratory health. Among these diagnostic devices are spirometers, which are essential tools for measuring lung function and diagnosing conditions such as asthma and chronic obstructive pulmonary disease (COPD). Spirometry tests provide valuable information about lung volume and airflow rates, aiding in the early detection and management of respiratory disorders.
Another important segment within diagnostic devices is polysomnographs, which are used in sleep studies to diagnose sleep-related breathing disorders such as sleep apnea. These devices monitor various physiological parameters during sleep, including airflow, oxygen levels, and brain activity, helping healthcare professionals evaluate sleep patterns and identify potential respiratory issues. Polysomnography plays a crucial role in diagnosing and treating sleep disorders, improving patient outcomes and quality of life.
Peak flow meters represent another key segment in the respiratory diagnostic devices market. These handheld devices measure the maximum airflow a person can generate during forced exhalation, providing valuable insights into airway function and identifying changes in lung function over time. Peak flow meters are commonly used by individuals with asthma to monitor their respiratory status and adjust medication dosages accordingly. By enabling early detection of changes in lung function, peak flow meters empower patients to take proactive steps in managing their respiratory health, ultimately improving their overall well-being.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, Segmentation by Monitoring Devices
The Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by Monitoring Devices into Pulse oximeters, Capnographs and Gas analyzers.
The Global Respiratory Devices and Equipment market is experiencing significant segmentation, particularly within the realm of Monitoring Devices. Among these, three key categories stand out: Pulse oximeters, Capnographs, and Gas analyzers. Pulse oximeters, widely recognized in medical settings, measure oxygen saturation levels in the blood. These devices are crucial in assessing respiratory health, especially in situations like asthma attacks or during surgeries where oxygen levels can fluctuate. Their non-invasive nature and ability to provide real-time data make them indispensable tools in respiratory care.
Capnographs, another integral component in respiratory monitoring, measure the concentration of carbon dioxide (CO2) in exhaled breath. This data is vital for assessing respiratory function and ensuring proper ventilation during procedures like anesthesia or mechanical ventilation. Capnography offers immediate feedback on respiratory status, aiding in timely intervention if abnormalities arise. Gas analyzers, on the other hand, provide a comprehensive assessment of the gases present in a patient's breath, including oxygen, carbon dioxide, and other volatile compounds. These devices offer insights into gas exchange efficiency and can help diagnose respiratory conditions such as chronic obstructive pulmonary disease (COPD) or monitor treatment effectiveness.
In essence, the segmentation of the Global Respiratory Devices and Equipment market into monitoring devices such as pulse oximeters, capnographs, and gas analyzers reflects the industry's focus on precision and comprehensive respiratory care. By leveraging these specialized tools, healthcare providers can better assess, monitor, and manage respiratory conditions, ultimately improving patient outcomes and quality of life.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, Segmentation by Application
The Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by Application into Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis and Pneumonia.
The Global Respiratory Devices and Equipment market is witnessing significant segmentation based on applications, reflecting the diverse range of respiratory conditions it addresses. Among these applications, asthma stands out as a prevalent respiratory disorder affecting millions worldwide. With the rising incidence of asthma cases globally, the demand for respiratory devices tailored to manage and alleviate symptoms continues to grow. Obstructive Sleep Apnea (OSA) is another key segment, highlighting the importance of respiratory devices in addressing sleep-related breathing disorders. The market's focus on OSA underscores the critical role of diagnostic and therapeutic devices in enhancing sleep quality and mitigating associated health risks.
Respiratory Distress Syndrome (RDS) emerges as a crucial segment within the market, particularly concerning neonatal care. As a leading cause of respiratory failure in premature infants, RDS necessitates specialized respiratory equipment to support lung function and aid in infant survival. Cystic Fibrosis, a genetic disorder affecting the respiratory and digestive systems, represents another significant application segment. The market's emphasis on cystic fibrosis underscores the ongoing need for innovative respiratory solutions to enhance patient outcomes and quality of life. Pneumonia, a common yet severe respiratory infection, further diversifies the market's application landscape, emphasizing the role of respiratory devices in managing acute respiratory illnesses and preventing complications.
In conclusion, the segmentation of the Global Respiratory Devices and Equipment market based on applications reflects the diverse spectrum of respiratory disorders it addresses, ranging from chronic conditions like asthma and cystic fibrosis to acute infections like pneumonia. This segmentation underscores the market's commitment to developing tailored solutions to meet the unique needs of patients across various respiratory health challenges. As technological advancements continue to drive innovation in respiratory care, the market is poised to witness further growth and evolution in addressing respiratory diseases comprehensively.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, Segmentation by Geography
In this report, the Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Share (%), by Geographical Region, 2024
In 2023, the global respiratory devices and equipment market witnessed a significant distribution of market share across various geographical regions. North America emerged as a dominant player, capturing a substantial portion of the market share. This can be attributed to several factors including high prevalence of respiratory diseases, advanced healthcare infrastructure, and increasing adoption of technologically advanced diagnostic and therapeutic equipment. Additionally, the presence of major market players and ongoing research and development activities further contributed to the region's market share in respiratory devices and equipment.
Following North America, Europe also secured a noteworthy share in the global respiratory devices and equipment market in 2023. The region's strong emphasis on healthcare, coupled with rising awareness about respiratory health among the population, drove the demand for diagnostic and therapeutic devices. Moreover, supportive government initiatives and favorable reimbursement policies encouraged the adoption of respiratory devices, thereby boosting the market share in Europe. With increasing investments in healthcare infrastructure and technological advancements, Europe remained a significant contributor to the global market landscape.
In Asia-Pacific, the respiratory devices and equipment market experienced rapid growth and captured a considerable share in 2023. Factors such as the large population base, rising pollution levels, and increasing prevalence of respiratory disorders propelled the demand for diagnostic and therapeutic solutions in the region. Furthermore, initiatives aimed at improving healthcare accessibility and affordability, along with growing healthcare expenditure, fueled the adoption of respiratory devices and equipment. As a result, Asia-Pacific emerged as a key market for respiratory devices, offering lucrative opportunities for market players to expand their presence and tap into the region's growing demand.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping.
Drivers, Restraints and Opportunity Analysis
Drivers
- Technological advancements in respiratory devices
-
Increasing prevalence of respiratory diseases - The global respiratory devices and equipment market is witnessing significant growth, fueled by the increasing prevalence of respiratory diseases worldwide. Respiratory illnesses, such as chronic obstructive pulmonary disease (COPD), asthma, and pneumonia, are among the leading causes of mortality and morbidity globally. Factors such as air pollution, smoking, and aging populations contribute to the rising incidence of these conditions. Consequently, there is a growing demand for therapeutic and diagnostic respiratory devices and equipment to manage and monitor these diseases effectively.
Therapeutic devices such as inhalers, nebulizers, positive airway pressure devices, and oxygen concentrators play a crucial role in the management of respiratory conditions. These devices help patients breathe more easily, improve lung function, and alleviate symptoms. Additionally, diagnostic equipment such as spirometers, peak flow meters, and polysomnography devices aid in the early detection, diagnosis, and monitoring of respiratory diseases, enabling timely interventions and better disease management.
Advancements in technology, such as the integration of wireless connectivity, remote monitoring capabilities, and miniaturization, are driving innovation in the respiratory devices market. These technological innovations enhance patient convenience, improve treatment adherence, and enable healthcare providers to deliver personalized care. Furthermore, initiatives aimed at raising awareness about respiratory health and improving access to healthcare services in emerging economies are expected to further boost market growth in the coming years.
Restraints
- High cost of respiratory devices and equipment
-
Stringent regulatory requirements - The global market for respiratory devices and equipment, encompassing both therapeutic and diagnostic tools, operates under stringent regulatory requirements aimed at ensuring patient safety and product efficacy. Regulatory bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and their counterparts worldwide impose rigorous standards on the development, manufacturing, and marketing of respiratory devices. These regulations mandate thorough testing, quality control measures, and compliance with specific standards to mitigate risks associated with respiratory therapies and diagnostics.
Compliance with regulatory requirements poses significant challenges for manufacturers in this industry. Meeting the stringent criteria often entails substantial investment in research, development, and manufacturing processes. Additionally, navigating the complex regulatory landscape demands expertise and resources, leading to increased time-to-market and operational costs. Companies must maintain continuous vigilance to adapt to evolving regulations, which may involve updating products, processes, or documentation to remain compliant and competitive in the market.
Despite the challenges, adherence to regulatory standards is essential for gaining market approval and maintaining consumer trust. Regulatory compliance not only ensures the safety and efficacy of respiratory devices but also enhances market access by facilitating approvals and certifications. Moreover, compliance serves as a benchmark for quality assurance, fostering customer confidence and fostering industry credibility.
Opportunities
- Growing demand for homecare respiratory devices
-
Emerging markets in developing countries - The global respiratory devices and equipment market is experiencing significant growth, particularly in emerging markets within developing countries. These regions are witnessing a surge in demand for respiratory devices due to various factors such as increasing pollution levels, rising prevalence of respiratory diseases like asthma and COPD (Chronic Obstructive Pulmonary Disease), and a growing geriatric population. Governments and healthcare organizations in these countries are also investing more in healthcare infrastructure, which includes the procurement of advanced respiratory devices and equipment to enhance patient care and management.
One of the primary drivers of growth in emerging markets is the expanding middle-class population with greater access to healthcare services. As disposable incomes rise, individuals are increasingly seeking better healthcare options, including diagnostic and therapeutic respiratory devices. Additionally, advancements in technology and the introduction of portable and user-friendly respiratory devices are further fueling market growth in these regions. Manufacturers are focusing on developing cost-effective solutions tailored to the needs of emerging markets, thereby making respiratory care more accessible to a larger segment of the population.
Awareness campaigns and initiatives by healthcare authorities and non-profit organizations are playing a crucial role in driving the adoption of respiratory devices in developing countries. These efforts aim to educate both healthcare professionals and the general public about the importance of early diagnosis and proper management of respiratory conditions. As a result, there is a growing demand for diagnostic tools such as spirometers and peak flow meters, as well as therapeutic devices like nebulizers, ventilators, and CPAP (Continuous Positive Airway Pressure) machines.
Competitive Landscape Analysis
Key players in Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market include :
- Philips Healthcare
- ResMed Inc.
- Medtronic plc
- Fisher & Paykel Healthcare
- Masimo Corporation
- Drägerwerk AG & Co. KGaA
- Smiths Medical
- GE Healthcare
- Hamilton Medical
- Invacare Corporation
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By End User
- Market Snapshot, By Therapeutic Devices
- Market Snapshot, By Diagnostic Devices
- Market Snapshot, By Monitoring Devices
- Market Snapshot, By Application
- Market Snapshot, By Region
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Technological advancements in respiratory devices
- Increasing prevalence of respiratory diseases
- Restraints
- High cost of respiratory devices and equipment
- Stringent regulatory requirements
- Opportunities
- Growing demand for homecare respiratory devices
- Emerging markets in developing countries
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By Type, 2021 - 2031 (USD Million)
- Diagnostic devices
- Therapeutic devices
- Monitoring devices.
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By End User, 2021 - 2031 (USD Million)
- Hospitals
- Clinics
- Homecare settings
- Ambulatory service centers
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By Therapeutic Devices, 2021 - 2031 (USD Million)
- Humidifiers
- Nebulizers
- Oxygen concentrators
- Positive Airway Pressure (PAP) Devices
- Ventilators
- Others
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By Diagnostic Devices, 2021 - 2031 (USD Million)
- Spirometer
- Polysomnographs
- Peak Flow Meters
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By Monitoring Devices, 2021 - 2031 (USD Million)
- Pulse oximeters
- Capnographs
- Gas analyzers
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By Application, 2021 - 2031 (USD Million)
- Asthma
- Obstructive Sleep Apnea (OSA)
- Respiratory Distress Syndrome (RDS)
- Cystic Fibrosis
- Pneumonia
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market, By Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Philips Healthcare
- ResMed Inc.
- Medtronic plc
- Fisher & Paykel Healthcare
- Masimo Corporation
- Drägerwerk AG & Co. KGaA
- Smiths Medical
- GE Healthcare
- Hamilton Medical
- Invacare Corporation
- Company Profiles
- Analyst Views
- Future Outlook of the Market